ArticleHeliyon2024
With whom should I work? Partners' network characteristics and innovation persistence.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural characteristics and evolutionary trajectories of knowledge recombination in the field of AI-driven drug discovery.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In studying the implications of collaboration networks on innovation persistence, previous research has primarily focused on the network characteristics of focal inventors, often overlooking those of their partners. The purpose of this study is to demonstrate what and how partners' network characteristics-specifically, network centrality and structural holes-affect the focal inventor's innovation persistence, by positing and testing the diversity and novelty of knowledge recombination as important mediators. We collected a panel patent dataset in the lithography industry between 2000 and 2023 and conducted data analysis using ordinary least squares (OLS) regression model, robustness test, and endogeneity test. Results indicate that partners' network centrality has an inverted U-shaped impact on innovation persistence, whereas partners' structural holes positively influence innovation persistence. The findings further show how the diversity and novelty of knowledge recombination mediate the relationships between partners' network characteristics and innovation persistence. This paper provides valuable insights for inventors, researchers, and policymakers, emphasizing the crucial role of partnerships and knowledge recombination in promoting innovation persistence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.